Novo Nordisk Resumes U.S. Supply of Wegovy 1.7 mg Dose

According to the Zhicheng Finance APP, after experiencing a short-term shortage in mid-December 2023, Novo Nordisk (NVO.US) resumed the supply of the 1.7 mg dose of the "weight-loss wonder drug" Wegovy in the United States in early January 2024.

In the U.S. Food and Drug Administration (FDA) drug shortage list, Wegovy in 1.7 mg and lower doses (0.25 mg, 0.5 mg, and 1 mg) is listed as supply constrained.

The website of Wegovy shows that the 2.4 mg dose of Wegovy is still available.